Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thyroid Nodule 1Prostatic Neoplasms 1Endometrial Neoplasms 1Coronary Artery Disease 1Carcinoma, Renal Cell 1

Interventions

Sunitinib 5Everolimus 5Nivolumab 4pazopanib 3cabozantinib 2aldesleukin 2palbociclib 1olaparib 1lenvatinib 1Zoledronic Acid 1Tobacco Use Cessation Devices 1Standard of Care 1Specimen Handling 1Sorafenib 1Single Person 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Nutrition Therapy 1Midazolam 1Ipilimumab 1Interferons 1Immune Checkpoint Inhibitors 1High-Energy Shock Waves 1Gene Expression Profiling 1Gemcitabine 1Erlotinib Hydrochloride 1Early Intervention, Educational 1Counseling 1Caffeine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Carcinoma, Renal Cell × High-Energy Shock Waves × Clear all
NCT03821376 2024-10-10

Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

Indiana University

Phase 4 Terminated
12 enrolled 6 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡